Acquired and intrinsic resistance to vemurafenib in <scp> BRAF <sup>V600E</sup> </scp> ‐driven melanoma brain metastasesPing Zhang, Mark C. de Gooijer, Laura E. Kuil et al.|FEBS Open Bio|2023Cited by 3
Abstract LB-255: Acquired and intrinsic resistance to vemurafenib in BRAF<sup>v600e</sup>-driven melanoma brain metastasesMark C. de Gooijer, Olaf van Tellingen, Ping Zhang et al.|Experimental and Molecular Therapeutics|2019Cited by 0
DDRE-01. ACQUIRED AND INTRINSIC RESISTANCE TO VEMURAFENIB IN BRAFV600E-DRIVEN MELANOMA BRAIN METASTASESMark C. de Gooijer, Olaf van Tellingen, Ping Zhang et al.|Neuro-Oncology|2020Cited by 0
Abstract LB-255: Acquired and intrinsic resistance to vemurafenib in BRAFv600e-driven melanoma brain metastasesMark C. de Gooijer, Olaf van Tellingen, Levi C.M. Buil et al.|Cancer Research|2019Cited by 0
Acquired and intrinsic resistance to vemurafenib in BRAF <sup>V600E</sup> -driven melanoma brain metastasesPing Zhang, Mark C. de Gooijer, Laura E. Kuil et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0